mNEXSPIKE 10 ug/.2mL
COVID-19 Vaccine, mRNA · INJECTION, SUSPENSION · Moderna US, Inc.
No Recall History
Plain English
mNEXSPIKE is a injection, suspension containing covid-19 vaccine, mrna at 10 ug/.2mL, taken intramuscular. Manufactured by Moderna US, Inc..
Key Facts
- Brand Name
- mNEXSPIKE
- Generic Name
- COVID-19 Vaccine, mRNA
- NDC Code (Product)
80777-400- Manufacturer
- Moderna US, Inc.
- Strength
- 10 ug/.2mL
- Dosage Form
- INJECTION, SUSPENSION
- Route
- INTRAMUSCULAR
- Marketing Status
- Application #
- BLA125835
- Marketing Start
- 08/27/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is mNEXSPIKE used for?
mNEXSPIKE contains COVID-19 Vaccine, mRNA. It is a injection, suspension taken intramuscular. Consult your doctor for specific uses.
Is mNEXSPIKE a controlled substance?
mNEXSPIKE is not classified as a controlled substance by the DEA.
What is the generic name for mNEXSPIKE?
The generic name for mNEXSPIKE is COVID-19 Vaccine, mRNA. There are 4 other brand versions of COVID-19 Vaccine, mRNA.
What is the NDC code for mNEXSPIKE 10 ug/.2mL?
The NDC (National Drug Code) for mNEXSPIKE 10 ug/.2mL is 80777-400, listed by Moderna US, Inc..